News
News

The latest updates from AFAR.

Board Member in the News: Caroline Blaum co-authors study on the impact of statin treatment in cardiovascular prevention among older adults in JAMA

May 25
2017

Board Member in the News: Caroline Blaum co-authors study on the impact of statin treatment in cardiovascular prevention among older adults in JAMA View MoreBACK

On May 22, 2017, JAMA Internal Medicine published a study co-authored by AFAR Deputy Medical Officer Caroline S. Blaum, MD that found statin treatments weren’t effective as a primary preventative for heart attacks or coronary heart disease deaths in adults aged 65 and older.

In Effect of Statin Treatment vs Usual Care on Primary Cardiovascular Prevention Among Older Adults, Dr. Blaum and fellow researchers sorted 2,867 participants—aged 65 and older, with high blood pressure and no evidence of plaque buildup in their arteries—into two groups. One group was prescribed to take 40 milligrams of pravastatin sodium treatment every day, and the other group was assigned usual care based on the discretion of their primary care physician.

The results found no significant difference between the two groups in the frequency of heart attacks, coronary heart disease deaths, nor deaths from any cause. Based on these results, researchers suggested that statins may have negative effects on function for vulnerable older adults.

The full JAMA Internal Medicine publication can be read here. The research was recognized in a related feature story in Medical News Today that can be viewed here.

Caroline S. Blaum, MD is Director of the Division of Geriatrics and Palliative Care and the Diane and Arthur Belfer Professor of Geriatric Medicine at NYU School of Medicine.


For more information on age-related diseases, we encourage you to explore our expert-edited Infoaging Center for Diseases and Aging here.





View MoreBACK TO TOP